- US12570650utility20266-substituted Pyridazine Compounds as SMARCA2 And/or SMARCA4 Degraders0 cites
- US12565515utility20261,2,4-oxadiazole Compounds as Inhibitors of CD47 Signalling Pathways0 cites
- US12428379utility2025Acylsulfonamide KAT6A Inhibitors0 cites
- US12410193utility2025Bicyclic Heterocyclyl Derivatives as IRAK4 Inhibitors0 cites
- US12377088utility2025Substituted Tetrahydroquinolinone Compounds as ROR Gamma Modulators0 cites
- US12331023utility2025Substituted Heterocyclyl Derivatives as CDK Inhibitors0 cites
- US12290507utility2025Methods of Use for Trisubstituted Benzotriazole Derivatives as Dihydroorotate Oxygenase Inhibitors0 cites
- US12268670utility2025Combination of Small Molecule CD-47 Inhibitors with Other Anti-cancer Agents0 cites
- US12226402utility2025Dual Inhibitors of TIM-3 and PD-1 Pathways0 cites
- US12187689utility2025Crystalline Forms of 3-substituted 1,2,4-oxadiazole0 cites
- US12064418utility2024Conjoint Therapies for Immunomodulation0 cites
- US12037321utility20241,2,4-oxadiazole Derivatives as Immunomodulators0 cites
- US12005045utility2024Method of Modulating TIGIT and PD-1 Signalling Pathways Using 1,2,4-oxadiazole Compounds0 cites
- US11981685utility2024Bicyclic Heterocyclyl Derivatives as IRAK4 Inhibitors0 cites
- US11865114utility2024Method for Treating Diseases Using SMARCA2/4 Degraders0 cites
- US11866420utility2024Hydrochloride Salt Forms of a Sulfonamide Structured Kinase Inhibitor0 cites
- US11633394utility2023Substituted Alkynylene Compounds as Anticancer Agents0 cites
- US11560403utility20231,2,4-oxadiazole Compounds as Inhibitors of CD47 Signaling Pathways0 cites